ALGSAccess Program
Improving access to medications, supplements, and services is a priority need for families affected by ALGS. The ALGSAccess Program was created to combat private and government insurance denials for medical care, medications and supplements, equipment, and other needs. Through this program, patients can receive support letters which aid in appealing for approval of VA services, disability, and other needs where related to Alagille Syndrome. If you have questions or need to talk through a denial of coverage, please connect with us via the contact for to the right.
HealthWell Foundation
HealthWell’s Alagille Syndrome Vitamins and Supplements Fund is designed to assist eligible people living with Alagille Syndrome with the full or partial cost-shares associated with vitamins and supplements. We are committed to supporting the ALGS community and the established guidelines around our covered product list are meant to focus on the areas of greatest need for the majority of people living with Alagille Syndrome. Please visit HealthWell’s website to locate the vitamins and supplements in the covered product list and the qualifications to enroll.
Medication Access Patient Program (MAPP)
We are proud to announce the launch of the Medication Access Patient Program (MAPP), created to help patients and families in South America affected by Alagille Syndrome with some out-of-pocket expenses for medications, vitamins, supplements, and formulas essential to their Alagille Syndrome related care.
Thank you to Tanner Pharma Group’s guidance and support in helping us develop this new and exciting program designed to help improve medication accessibility for patients who truly need it.
“We commend the Alagille Syndrome Alliance for their dedication and perseverance in developing an innovative program to address barriers to the access of essential medicines for Alagille syndrome patients. When there is a will, there is a way, and we look forward to continuing to support their mission to help patients get the medicines they need.”
– Rob Keel, Executive Vice President, Tanner Pharma Group
“Through the extraordinary efforts of expanding our programs and services internationally, we have built an amazing base of families in South America and have come to more deeply understand the challenges and hardships they face geographically, financially, and economically. We have watched families suffer from medication access issues for many years for reasons mostly outside of their control. We are honored to have had Tanner Pharma Group’s guidance and support through the development of this outstanding program and we look forward to helping families in this direct and very meaningful way.”
– Roberta Smith, President, Alagille Syndrome Alliance.
To apply, patients or caregivers will download, print, and complete the MAPP Waiver and Application form and return it to mapp@alagille.org.
Only available for patients and families living in Brazil at this time.